• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' reply.社论：非酒精性脂肪性肝病（NAFLD）的临床结局——细节决定成败。作者回复。
Aliment Pharmacol Ther. 2023 May;57(9):1042-1043. doi: 10.1111/apt.17453.
2
Editorial: clinical outcomes in lean NAFLD-the devil is in the details.社论：非酒精性脂肪性肝病（NAFLD）患者的临床结局——细节决定成败。
Aliment Pharmacol Ther. 2023 May;57(9):1040-1041. doi: 10.1111/apt.17449.
3
Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer. Authors' reply.社论：亚洲的非酒精性脂肪性肝病——与晚期疾病的临床关联日益明晰。作者回复。
Aliment Pharmacol Ther. 2018 Apr;47(7):1037-1038. doi: 10.1111/apt.14572.
4
Editorial: collagen proportionate area as a prognostic indicator in NAFLD-authors' reply.社论：胶原比例面积作为非酒精性脂肪性肝病的预后指标——作者回复
Aliment Pharmacol Ther. 2019 Jun;49(11):1454-1455. doi: 10.1111/apt.15271.
5
Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply.编者按：非酒精性脂肪性肝病患者F3和F4的逐步风险分层——作者回复
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1318-1319. doi: 10.1111/apt.15040.
6
Editorial: NAFLD in HIV infection--call for action. Authors' reply.社论：HIV感染中的非酒精性脂肪性肝病——呼吁采取行动。作者回复。
Aliment Pharmacol Ther. 2015 Mar;41(6):591. doi: 10.1111/apt.13087.
7
Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD - authors' reply.社论：使用先进磁共振成像技术监测非酒精性脂肪性肝病的更多证据——作者回复
Aliment Pharmacol Ther. 2017 May;45(9):1271-1272. doi: 10.1111/apt.14037.
8
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.社论：重新审视非酒精性脂肪性肝病合并晚期纤维化时的心血管危险因素？作者回复。
Aliment Pharmacol Ther. 2020 May;51(10):988-989. doi: 10.1111/apt.15696.
9
Editorial: targeting liver biopsy in NAFLD-the need to expand our non-invasive tools. Authors' reply.社论：非酒精性脂肪性肝病肝活检的靶向治疗——拓展非侵入性工具的必要性。作者回复。
Aliment Pharmacol Ther. 2022 Jan;55(1):128. doi: 10.1111/apt.16711.
10
Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD? Authors' reply.社论：基于尿液的代谢组学能否改善非酒精性脂肪性肝病晚期纤维化的诊断？作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(11):1205-1206. doi: 10.1111/apt.15756.

本文引用的文献

1
Editorial: clinical outcomes in lean NAFLD-the devil is in the details.社论：非酒精性脂肪性肝病（NAFLD）患者的临床结局——细节决定成败。
Aliment Pharmacol Ther. 2023 May;57(9):1040-1041. doi: 10.1111/apt.17449.
2
Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities.非酒精性脂肪性肝病消瘦患者的死亡率较高，尽管合并代谢性合并症较少。
Aliment Pharmacol Ther. 2023 May;57(9):1014-1027. doi: 10.1111/apt.17424. Epub 2023 Feb 23.
3
Long-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis.长期体重变化与非酒精性脂肪性肝病诊断后的初始体重变化有关。
Hepatol Commun. 2023 Feb 9;7(3):e0044. doi: 10.1097/HC9.0000000000000044. eCollection 2023 Mar 1.
4
Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.瘦型非酒精性脂肪性肝病与非瘦型非酒精性脂肪性肝病患者的死亡率和肝脏相关事件：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2496-2507.e5. doi: 10.1016/j.cgh.2022.11.019. Epub 2022 Nov 26.
5
Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort.非侵入性指标诊断肝脂肪变性的准确性与真实世界队列中影像学的比较。
Dig Dis Sci. 2022 Nov;67(11):5300-5308. doi: 10.1007/s10620-022-07415-w. Epub 2022 Feb 15.
6
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
7
Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population.磁共振弹性成像在健康体检人群中检测显著肝纤维化的流行率。
Aliment Pharmacol Ther. 2020 Feb;51(3):388-396. doi: 10.1111/apt.15626.
8
Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.一般人群中用非侵入性肝纤维化标志物定义的临床显著肝脏疾病的流行情况：系统评价。
Lancet Gastroenterol Hepatol. 2017 Apr;2(4):288-297. doi: 10.1016/S2468-1253(16)30205-9. Epub 2017 Feb 1.

Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' reply.

作者信息

Wijarnpreecha Karn, Lok Anna S, Chen Vincent L

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.

出版信息

Aliment Pharmacol Ther. 2023 May;57(9):1042-1043. doi: 10.1111/apt.17453.

DOI:10.1111/apt.17453
PMID:37053482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10707450/
Abstract
摘要